• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Coppersmith Capital Management

Will Medtronic abandon inversion in Covidien deal? | Medtech Wall Street news for the week of August 18, 2014

August 21, 2014 By MassDevice Contributors Network Leave a Comment

Will Medtronic follow Walgreen and abandon inversion in Covidien deal?

August 15, 2014 by Brad Perriello

Filed Under: News Well, Wall Street Beat Tagged With: Allergan, ConMed Corp., Coppersmith Capital Management, Covidien, electroCore, Pershing Square Capital Management, Piper Jaffray, Valeant Pharmaceuticals, Voce Capital Management

Activist investor battles on over ConMed as shareholders vote approaches

August 14, 2014 By Brad Perriello Leave a Comment

Hedge funds battle over ConMed's board as shareholders meeting approaches

Filed Under: News Well, Wall Street Beat Tagged With: ConMed Corp., Coppersmith Capital Management, Voce Capital Management

Embattled ConMed surges on reports of potential sale

April 16, 2014 By Arezu Sarvestani Leave a Comment

ConMed surges on reports of potential sale

Surgical devices maker ConMed (NSDQ:CNMD) got a little Wall Street love after news sources reported today that the company may be up for sale.

Filed Under: Mergers & Acquisitions, News Well, Surgical, Wall Street Beat Tagged With: ConMed Corp., Coppersmith Capital Management, Voce Capital Management

K2M Group Holdings looks to raise $100M in IPO | Medtech Wall Street stories for the week of Mar. 17, 2014

March 19, 2014 By MassDevice staff Leave a Comment

Spinal firm K2M aims for $100M IPO

March 14, 2014 by Arezu Sarvestani

Spinal firm K2M aims for $100M IPO

Filed Under: News Well, Wall Street Beat Tagged With: Biolase, ConMed Corp., Coppersmith Capital Management, K2M, Oracle Partners, Voce Capital Management

ConMed delays annual meeting amid proxy war

March 17, 2014 By Brad Perriello Leave a Comment

ConMed delays annual meeting amid proxy war

ConMed (NSDQ:CNMD) said last week that it’s delaying its annual shareholders meeting amid a 3-way proxy war that turned nasty last month.

Filed Under: News Well, Wall Street Beat Tagged With: ConMed Corp., Coppersmith Capital Management, Voce Capital Management

Medtech personnel moves for the week of Mar. 10, 2014

March 11, 2014 By MassDevice staff Leave a Comment

ConMed proxy war gets ugly

February 28, 2014 by Brad Perriello

ConMed proxy war gets ugly

The proxy war over control of the board at ConMed turned ugly this week after serious allegations surfaced against 1 of the medical device company’s nominees for director.

Filed Under: News Well Tagged With: Alere, becton dickinson, Boston Scientific, Carlyle Group, ConMed Corp., Coppersmith Capital Management, Cutera Inc., Delcath Systems Inc., Johnson and Johnson, Kaiser Permanente Ventures, Masimo, Merck KGaA, Millipore Corp., National Quality Forum, Ortho-Clinical Diagnostics, Personnel Moves, Premier Inc., Roche, Stryker, Varian Medical Systems, Vexim, Voce Capital Management

ConMed proxy war gets ugly

February 28, 2014 By Brad Perriello Leave a Comment

ConMed proxy war gets ugly

UPDATED March 4, 2014, with comment from Coppersmith Capital.

The proxy war over control of the board at ConMed (NSDQ:CNMD) turned ugly this week after serious allegations surfaced against 1 of the medical device company’s nominees for director.

Filed Under: News Well, Wall Street Beat Tagged With: Alere, ConMed Corp., Coppersmith Capital Management, Personnel Moves, Stryker, Voce Capital Management

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy